Summit backs Viroclinics Biosciences
Summit Partners has made an investment in Viroclinics Biosciences, a Dutch contract research organization serving the global biopharmaceutical industry.
3 March 2020•3 mins read
Summit Partners has made an investment in Viroclinics Biosciences, a Dutch contract research organization serving the global biopharmaceutical industry.
Paradigm Equity Partners acquires upholstery and performance fabric maker STI Fabrics
15 hours ago · 1 min read
KKR and Hildred merge diagnostics businesses Sapphiros and binx health into Onvaro
15 hours ago · 2 mins read
Eir Partners-backed Porter acquires health plan analytics firm Pareto Intelligence
15 hours ago · 1 min read
Bain Capital’s LeanTaaS snaps up hospital care transition platform Aidin
16 hours ago · 2 mins read
Carlyle-backed Vantive agrees hemodialysis business sale to Rockwell Medical
16 hours ago · 2 mins read
Novacap completes OSI Maritime Systems acquisition as first Fund VII deal
16 hours ago · 2 mins read
Long Arc-backed Robertson Stephens adds Denver adviser Altius Financial
16 hours ago · 1 min read
